Show simple item record

dc.contributor.authorBloor, Adrian
dc.contributor.authorPatel, A
dc.contributor.authorGriffin, E
dc.contributor.authorGilleece, H
dc.contributor.authorRadia, R
dc.contributor.authorYeung, T
dc.contributor.authorSlukvin, I
dc.contributor.authorKelly, K
dc.contributor.authorRasko, J
dc.date.accessioned2019-03-29T14:22:32Z
dc.date.available2019-03-29T14:22:32Z
dc.date.issued2018en
dc.identifier.citationBloor A, Patel A, Griffin J, Gilleece M, Radia R, Yeung D, et al. A phase I trial of iPSC-derived MSCs (CYP-001) in steroid-resistant acute GvHD. Blood. 2018;132.en
dc.identifier.doi10.1182/blood-2018-99-110432en
dc.identifier.urihttp://hdl.handle.net/10541/621672
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1182/blood-2018-99-110432en
dc.titleA phase I trial of iPSC-derived MSCs (CYP-001) in steroid-resistant acute GvHDen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Royal Marsden NHS Foundation Trust, Londonen
dc.identifier.journalBlooden
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record